166 related articles for article (PubMed ID: 11299327)
1. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate.
Nixdorf WL; Burrows KB; Gudelsky GA; Yamamoto BK
J Neurochem; 2001 Apr; 77(2):647-54. PubMed ID: 11299327
[TBL] [Abstract][Full Text] [Related]
2. Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
Goñi-Allo B; Ramos M; Herv'as I; Lasheras B; Aguirre N
J Psychopharmacol; 2006 Mar; 20(2):245-56. PubMed ID: 16510482
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
Darvesh AS; Gudelsky GA
Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
Darvesh AS; Yamamoto BK; Gudelsky GA
J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
Nair SG; Gudelsky GA
Brain Res; 2004 Jul; 1013(2):168-73. PubMed ID: 15193525
[TBL] [Abstract][Full Text] [Related]
6. L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.
Breier JM; Bankson MG; Yamamoto BK
J Neurosci; 2006 Jan; 26(1):290-9. PubMed ID: 16399699
[TBL] [Abstract][Full Text] [Related]
7. Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.
Baumann MH; Clark RD; Rothman RB
Pharmacol Biochem Behav; 2008 Aug; 90(2):208-17. PubMed ID: 18403002
[TBL] [Abstract][Full Text] [Related]
8. Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines.
Burrows KB; Nixdorf WL; Yamamoto BK
J Pharmacol Exp Ther; 2000 Mar; 292(3):853-60. PubMed ID: 10688597
[TBL] [Abstract][Full Text] [Related]
9. MDMA induced dopamine release in vivo: role of endogenous serotonin.
Koch S; Galloway MP
J Neural Transm (Vienna); 1997; 104(2-3):135-46. PubMed ID: 9203077
[TBL] [Abstract][Full Text] [Related]
10. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
Gudelsky GA; Nash JF
J Neurochem; 1996 Jan; 66(1):243-9. PubMed ID: 8522960
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Goñi-Allo B; Puerta E; Hervias I; Di Palma R; Ramos M; Lasheras B; Aguirre N
Eur J Pharmacol; 2007 May; 562(3):198-207. PubMed ID: 17320075
[TBL] [Abstract][Full Text] [Related]
12. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor.
Amato JL; Bankson MG; Yamamoto BK
Neuropsychopharmacology; 2007 Apr; 32(4):946-54. PubMed ID: 16885935
[TBL] [Abstract][Full Text] [Related]
13. Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain.
Riegert C; Wedekind F; Hamida SB; Rutz S; Rothmaier AK; Jones BC; Cassel JC; Jackisch R
Int J Neuropsychopharmacol; 2008 Sep; 11(6):743-63. PubMed ID: 18248690
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.
Baumann MH; Clark RD; Franken FH; Rutter JJ; Rothman RB
Neuroscience; 2008 Mar; 152(3):773-84. PubMed ID: 18313226
[TBL] [Abstract][Full Text] [Related]
15. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
Shankaran M; Gudelsky GA
Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
[TBL] [Abstract][Full Text] [Related]
16. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
Johnson BN; Yamamoto BK
J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
[TBL] [Abstract][Full Text] [Related]
17. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
[TBL] [Abstract][Full Text] [Related]
18. Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin.
Gudelsky GA
J Neural Transm (Vienna); 1996; 103(12):1397-404. PubMed ID: 9029406
[TBL] [Abstract][Full Text] [Related]
19. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
[TBL] [Abstract][Full Text] [Related]
20. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
Nash JF; Brodkin J
J Pharmacol Exp Ther; 1991 Nov; 259(2):820-5. PubMed ID: 1682486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]